Skip to main content

Neoantigens Enable Personalized Cancer Immunotherapy

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

Written byStephen P. Schoenberger and Ezra Cohen
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00

© JOVAN VAITANOVSKI/SHUTTERSTOCK.COM

A cancer diagnosis often results in any number of relatively nonspecific treatments, such as surgery, radiation, or chemotherapy, all of which can destroy healthy tissue along with the tumor. Seeking approaches that could successfully eradicate tumors while avoiding such collateral damage from aggressive therapy, researchers have developed a number of treatments targeted to specific types of tumors and, more recently, a handful of therapies aimed at modulating the body’s immune cells to more effectively fight its cancer. Mounting evidence suggests that such immunotherapies can effectively turn patients’ own immune systems against the very molecules that distinguish the tumor from normal cells, allowing the body’s T cells to serve as guided missiles that seek and destroy only the intended target.

Mounting evidence suggests that immunotherapies can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Published In

April 2017

Targeting Tumors

Precision aim to spare healthy cells

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays